Details
| Stereochemistry | MIXED |
| Molecular Formula | C14H19N |
| Molecular Weight | 201.3074 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1C2CCC(C2)C1C3=CC=CC=C3
InChI
InChIKey=CTVMYAZECFXZLN-UHFFFAOYSA-N
InChI=1S/C14H19N/c1-15-14-12-8-7-11(9-12)13(14)10-5-3-2-4-6-10/h2-6,11-15H,7-9H2,1H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Camfetamine
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID401017199
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
PRIMARY | |||
|
57504017
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
PRIMARY | |||
|
3E7N2GO76U
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
PRIMARY | |||
|
Camfetamine
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
PRIMARY | Camfetamine (N-methyl-3-phenyl-norbornan-2-amine) is a stimulant drug closely related to the appetite suppressant fencamfamine, being its N-methyl homologue. It has been sold as a designer drug following the banning of mephedrone and related substituted cathinone derivatives in many countries, and reportedly has slightly stronger stimulant effects than fencamfamine, but with correspondingly more severe side effects. | ||
|
N-METHYL-3-PHENYLBICYCLO(2.2.1)HEPTAN-2-AMINE
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
PRIMARY | Camfetamine is the N-methyl analogue of norFencamfamine, producing it's effects primarily as a dopamine reuptake inhibitor, appearing on the RC scene in 2011. Dosage: Effects and contraindications are likely to be similar to similar to fencafamine: Light: 50-100mg; common 100-150mg; heavy: 200-250mg+ | ||
|
92499-19-9
Created by
admin on Mon Mar 31 23:21:12 GMT 2025 , Edited by admin on Mon Mar 31 23:21:12 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)